Trilogy Capital’s State Street DoubleLine Short Duration Total Return Tactical ETF STOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$271K Buy
5,759
+16
+0.3% +$753 0.01% 348
2026
Q1
$271K Buy
5,743
+360
+7% +$17K 0.01% 339
2025
Q4
$254K Buy
5,383
+14
+0.3% +$663 0.01% 340
2025
Q3
$254K Buy
5,369
+9
+0.2% +$426 0.01% 341
2025
Q2
$254K Buy
5,360
+290
+6% +$13.7K 0.01% 321
2025
Q1
$240K Buy
5,070
+6
+0.1% +$282 0.01% 311
2024
Q4
$237K Buy
+5,064
New +$238K 0.01% 306

Other funds holding STOT

Trilogy Capital's STOT Position: Q2 2026 in Review

Trilogy Capital increased its State Street DoubleLine Short Duration Total Return Tactical ETF (STOT) stake by 0.28% in Q2 2026, buying an estimated $753 and bringing the position to 5,759 shares worth $271K. The position accounts for 0.01% of the portfolio, ranked #348.

Trilogy Capital first reported a position in STOT in Q4 2024 and has held it in 7 quarters since. 10 funds tracked by Wall St. Rank hold STOT as of Q2 2026.

  • Trilogy Capital held 5,759 shares of State Street DoubleLine Short Duration Total Return Tactical ETF worth $271K as of Q2 2026.
  • Trilogy Capital bought 16 State Street DoubleLine Short Duration Total Return Tactical ETF shares in Q2 2026, an estimated $753.
  • State Street DoubleLine Short Duration Total Return Tactical ETF made up 0.01% of Trilogy Capital's portfolio in Q2 2026, its #348 holding.
  • Trilogy Capital first reported a position in State Street DoubleLine Short Duration Total Return Tactical ETF in Q4 2024 and has held it in 7 quarters since.
  • 10 funds tracked by Wall St. Rank held State Street DoubleLine Short Duration Total Return Tactical ETF as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.